Radical oncologic surgery affects the circulatory levels of interleukin 10

Journal of Surgical Oncology

Volumn 66, Issue 4, 1997, Pages 244-247

  Gianotti, Luca ^a,b   Fortis, Claudio ^a   Braca, Marco ^a   Gentilini, Oreste ^a   Vignali, Andrea ^a   Di Carlo, Valerio ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Adenocarcinoma; Interleukin 10; Neoplasm; Oncologic surgery

Indexed keywords

INTERLEUKIN 10;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER PALLIATIVE THERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; DIGESTIVE SYSTEM CANCER; FEMALE; FIBROMA; HUMAN; MALE; PRIORITY JOURNAL;

ADENOCARCINOMA; AGED; COLECTOMY; FEMALE; FIBROMA; GASTRECTOMY; GASTROINTESTINAL NEOPLASMS; HUMANS; HYSTERECTOMY; INTERLEUKIN-10; MALE; MIDDLE AGED; PANCREATECTOMY; PANCREATIC NEOPLASMS; UTERINE NEOPLASMS;

EID: 0031455624     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199712)66:4<244::AID-JSO4>3.0.CO;2-B     Document Type: Article

References (20)

1. Howard M, O'Garra A, Ishida H, et al.: Biologic properties of interleukin-10. J Clin Immunol 1992;12:239-247.
2. Taga K, Mostowski H, Tosato G: Human interleukin-10 can directly inhibit T-cell growth. Blood 1993;81:2964-2971.
3. De Waal Malefyt R, Abrams J, Bennet B, et al.: Interleukin-10 (IL-10) inhibits cytokine synthesis by human monocytes: An autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991;174:1209-1220.
4. Holland G, Zlotnik A: Interleukin-10 and cancer. Cancer Invest 1993;11:751-758.
5. Nabioullin R, Sone S, Mizuno K, et al.: Interleukin-10 is a potent inhibitor of tumor cytotoxicity by human monocytes and alveolar macrophages. J Leukocyte Biol 1994:55:437-442.
6. Fortis C, Foppoli M, Gianotti L, et al.: Increased interleukin-10 serum levels in patients with solid tumours. Cancer Lett 1996; 104:1-5.
7. Maffezzini M, Simonato A, Fortis C: Salvage immunotherapy with subcutaneous IL-2 and alpha-INF for stage D3 prostate carcinoma failing second line hormonal treatment. Prostate 1996;28: 282-286.
8. Merville P, Rousset F, Banchereau J, et al.: Serum interleukin-10 in early stage multiplee myeloma. Lancet 1992;340:1544-1545.
9. Blay JY, Burdin N, Roussel F, et al.: Serum interleukin-10 in non-Hodgkin's lymphoma: A prognostic factor. Blood 1993;82: 2169-2174.
10. Chen Q, Daniel V, Maher DW. Production of IL-10 by melanoma cells: Examination of its role in immunosuppression mediated melanoma. Int J Cancer 1994;56:755-760.
11. Gastl GA, Abrams JS, Nanus DM, et al.: Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer 1993;55:96-101.
12. Gianotti L, Braga M, Radaelli G, et al.: Lack of improvement of prognostic performance of weight loss when combined with other nutritional parameters. Nutrition 1995;11:12-16.
13. th ed. Berlin: Springer-Verlag, 1987.
14. Kambayashi T, Alexander HR, Fong M, Strassmann G: Potential involvement of IL-10 in suppressing tumour-associated macrophages. J Immunol 1995;155:3383-3390.
15. Filgueira L, Zuber M, Merlo A, et al.: Cytokine gene transcription in renal cell carcinoma. Br J Surg 1993;80:1322-1325.
16. Pisa P, Halapi E, Pisa EK, et al.: Selective expression of interleukin-10, interferon gamma, and granulocyte-macrophage colony-stimulating factor in ovarian cancer biopsies. P Natl Acad Sci USA 1992;89:7708-7712.
17. Kruger-Krasagakis S, Krasagakis K, Garbe C, et al.: Expression of interleukin-10 in human melanoma. Br J Cancer 1993;70:1182-1185.
18. Smith DR, Kunkel SL, Burdick MD, et al.: Production of interleukin-10 by human bronchogenic carcinoma. Am J Pathol 1994; 145:18-25.
19. Pirenne J, Jalali H, Lirnet R, De Groote D. Effect of surgery on interleukin-10 production. [abstract] Current Options in Surgical Infection 1995;3 (Suppl I).
20. Ragazzi S, Carlucci M, Gianotti L, et al. Relationship between cytokine kinetics and prognosis in trauma patients. J Emerg Surg Intensive Care 1996;19:51-58.